PFIZER DERMATOLOGY PATIENT ACCESS Trademark

Trademark Overview

On Thursday, December 17, 2020, a trademark application was filed for PFIZER DERMATOLOGY PATIENT ACCESS with the United States Patent and Trademark Office. The USPTO has given the PFIZER DERMATOLOGY PATIENT ACCESS trademark a serial number of 90389758. The federal status of this trademark filing is REGISTERED as of Tuesday, September 5, 2023. This trademark is owned by Pfizer Inc.. The PFIZER DERMATOLOGY PATIENT ACCESS trademark is filed in the Insurance & Financial Services category with the following description:

Medical services, namely, providing financial information related to medical coverage, financial support, and pharmacy fulfillment related to the treatment of dermatological conditions; online information services, namely, providing financial information related to medical coverate, financial support, and pharmacy fulfillment related to the treatment of dermatological conditions
pfizer dermatology patient access

General Information

Serial Number90389758
Word MarkPFIZER DERMATOLOGY PATIENT ACCESS
Filing DateThursday, December 17, 2020
Status700 - REGISTERED
Status DateTuesday, September 5, 2023
Registration Number7157897
Registration DateTuesday, September 5, 2023
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 12, 2022

Trademark Statements

Description of MarkThe mark consists of the words PFIZER DERMATOLOGY PATIENT ACCESS where the beginning letter "A" of the word Access is a stylized lock.
Goods and ServicesMedical services, namely, providing financial information related to medical coverage, financial support, and pharmacy fulfillment related to the treatment of dermatological conditions; online information services, namely, providing financial information related to medical coverate, financial support, and pharmacy fulfillment related to the treatment of dermatological conditions
NOT AVAILABLE"DERMATOLOGY PATIENT ACCESS"

Classification Information

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, April 29, 2022
Primary Code036
First Use Anywhere DateSaturday, December 31, 2022
First Use In Commerce DateSaturday, December 31, 2022

Trademark Owner History

Party NamePfizer Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10001-219
Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10001-219
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Friday, February 26, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 21, 2020NEW APPLICATION ENTERED
Saturday, February 27, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, April 15, 2021ASSIGNED TO EXAMINER
Thursday, April 22, 2021NON-FINAL ACTION WRITTEN
Thursday, April 22, 2021NON-FINAL ACTION E-MAILED
Thursday, April 22, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 13, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 16, 2021FINAL REFUSAL E-MAILED
Wednesday, October 13, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 13, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 16, 2021FINAL REFUSAL WRITTEN
Tuesday, November 16, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, April 29, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, April 29, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 29, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 7, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 22, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 12, 2022PUBLISHED FOR OPPOSITION
Tuesday, July 12, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 6, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, March 3, 2023SOU TEAS EXTENSION RECEIVED
Friday, March 3, 2023SOU EXTENSION 1 FILED
Friday, March 3, 2023SOU EXTENSION 1 GRANTED
Tuesday, March 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 28, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 28, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 28, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 28, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 28, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 29, 2023TEAS STATEMENT OF USE RECEIVED
Thursday, June 29, 2023USE AMENDMENT FILED
Friday, June 30, 2023SOU TEAS EXTENSION RECEIVED
Friday, June 30, 2023SOU EXTENSION 2 FILED
Monday, July 10, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 11, 2023SOU EXTENSION 2 GRANTED
Tuesday, July 11, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, July 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 1, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, August 2, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 5, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, September 5, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

access patient dermatology pfizer financial related information medical fulfillment treatment dermatological conditions pharmacy support